Biora Therapeutics, INC.: management transactions · United States · SEC (Form 4) SEC:biora-therapeutics-inc-7d3054 US US · SEC (Form 4) Mcap 777.3Bn€ Technology
Browse the full insider trade history of Biora Therapeutics, INC., a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Technology sector, Biora Therapeutics, INC. has logged 8 insider filings. Market capitalisation: €777.3bn. The latest transaction was filed on 17 June 2022 — Attribution. Among the most active insiders: Kotzin Brian L.. All data is free.
Financial data FY ended August 2025 · cache
Analyst consensus
41 analysts 249.00 € Target 584.24 € 1000.00 €
Income statement
Revenue 37.38 Bn€
Gross profit 14.87 Bn€ 40% margin
Net income 8.54 Bn€ 41.5% margin
Valuation
PER (trailing) 32.6x
PER (forward) 6.7x
P/Book 10.7x
Beta 1.92
Balance sheet & cash
Market cap 777.35 Bn€
Total debt 15.28 Bn€
Free Cash Flow 1.67 Bn€
Debt / Equity 15%
Profitability & ownership
ROE 39.8%
ROA 20.1%
% insiders 0.3%
% institutions 81.1%
Last declaration on 17 June 2022
Declarations 8 total
Executives ◆ Grant16 SEC
096,154 shares 0
Common Stock
SEC:0000899243-22-023092:0 · 15 Jun 2022
Executives ◆ Grant16 SEC
096,154 shares 0
Common Stock
SEC:0000899243-22-023091:0 · 15 Jun 2022
Executives ◆ Grant16 SEC
096,154 shares 0
Common Stock
SEC:0000899243-22-023096:0 · 15 Jun 2022
Executives ◆ Grant16 SEC
096,154 shares 0
Common Stock
SEC:0000899243-22-023090:0 · 15 Jun 2022
Executives ◆ Grant16 SEC
096,154 shares 0
Common Stock
SEC:0000899243-22-023089:0 · 15 Jun 2022
Executives ● Retenue fiscale15 SEC
€5,989 8,305 shares @ €0.7211 0.0000% mcap 100.0% of flow
Common Stock
SEC:0000899243-22-018432:0 · 15 May 2022
Executives ● Retenue fiscale32 SEC
€7,490 10,387 shares @ €0.7211 0.0000% mcap 100.0% of flow
Common Stock
SEC:0000899243-22-018428:0 · 15 May 2022
Executives ◆ Grant27 SEC
01,562,500 shares 0
Common Stock
SEC:0000899243-22-018429:0 · 15 May 2022